500 results on '"Jha, Manish K."'
Search Results
52. Association of T and non-T cell cytokines with anhedonia: Role of gender differences
53. Adiponectin moderates antidepressant treatment outcome in the combining medications to enhance depression outcomes randomized clinical trial
54. Psychometric properties of the concise health risk tracking (CHRT) in adolescents with suicidality
55. Characterizing anxiety subtypes and the relationship to behavioral phenotyping in major depression: Results from the EMBARC study
56. Peripheral biomarkers of major depression and antidepressant treatment response: Current knowledge and future outlooks
57. A Structured Approach to Detecting and Treating Depression in Primary Care: VitalSign6 Project
58. Do baseline sub-threshold hypomanic symptoms affect acute-phase antidepressant outcome in outpatients with major depressive disorder? Preliminary findings from the randomized CO-MED trial
59. Interleukin 17 selectively predicts better outcomes with bupropion-SSRI combination: Novel T cell biomarker for antidepressant medication selection
60. Proteomics profiling reveals inflammatory biomarkers of antidepressant treatment response: Findings from the CO-MED trial
61. #111 - - Immune biomarkers in psychiatric illness: Findings from the biomarker subgroup of the NSAS Brain-Immune Interactions Workshop
62. Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression
63. Effect of pimavanserin on anxious depression in patients with major depression and an inadequate response to previous therapy: secondary analysis of the clarity study
64. Comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment resistant depression (ASCERTAIN-TRD) a randomized clinical trial
65. Can C-reactive protein inform antidepressant medication selection in depressed outpatients? Findings from the CO-MED trial
66. Early normalization of Quality of Life predicts later remission in depression: Findings from the CO-MED trial
67. Pharmacotherapies for Treatment-Resistant Depression: How Antipsychotics Fit in the Rapidly Evolving Therapeutic Landscape
68. Early reduction in irritability is associated with improved outcomes among youth with depression: Findings from the AMOD study
69. The Making of New Dalit Middle Class: Struggle, Aspirations and Changing Lifestyle in Navi Mumbai, India
70. Nationalism and populist politics: the migrant-citizen conundrum in Assam
71. The real-world burden of adults with major depressive disorder with moderate or severe insomnia symptoms in the United States
72. A randomized pilot study of the prophylactic effect of ketamine on laboratory-induced stress in healthy adults
73. Intranasal esketamine effectively treats treatment-resistant depression in adults regardless of baseline irritability
74. Pharmacogenomics and Biomarkers of Depression
75. The clinical, economic, and patient‐centric burden of insomnia symptom severity in adults with major depressive disorder in the United States.
76. MDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study.
77. Rapidity of Symptom Improvement With Intranasal Esketamine for Major Depressive Disorder
78. Effect of Concomitant Benzodiazepines on the Antidepressant Effects of Ketamine
79. Immune characterization of suicidal behavior in female adolescents
80. Biopolitics and Urban Governmentality in Mumbai
81. Correction: Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
82. A pilot program for implementing mental health screening, assessment, and navigation in a community‐based cancer center
83. Human security crisis in India
84. Teaching Motivational Interviewing Skills to Psychiatry Trainees: Findings of a National Survey
85. P310. Effect of a Sub-Anesthetic Infusion of Ketamine on Laboratory-Induced Stress in Healthy Volunteers: A Proof-Of-Concept Translational Study
86. Pandemic precarity and the complicated case of Maharashtra: Interrogating state capacity and its fault lines
87. Patterns of Pretreatment Reward Task Brain Activation Predict Individual Antidepressant Response: Key Results From the EMBARC Randomized Clinical Trial
88. A primary care first (PCP-first) model to screen and treat depression: A VitalSign6 report from a second cohort of 32,106 patients
89. Community development practice in India: Interrogating caste and common sense
90. Community organising and political agency: changing community development subjects in India
91. Food security in perspective: the significance of social action
92. Dysregulation of mitochondrial dynamics, mitophagy and apoptosis in major depressive disorder: Does inflammation play a role?
93. 23.1 Irritability/Dysregulation
94. Availability and Attitudes Toward Correctional Psychiatry Training: Results of a National Survey of Training Directors
95. Social construction of migrant identities: everyday life of Bangladeshi migrants in West Bengal.
96. Neoliberal Governmentality and Social Policymaking in India: Implications for In/Formal Workers and Community Work
97. Irritability as an independent predictor of concurrent and future suicidal ideation in adults with stimulant use disorder: Findings from the STRIDE study
98. Sex-specific differences in the association between body mass index and brain aging in young adults: Findings from the human connectome project
99. sj-docx-1-jop-10.1177_0269881120985147 – Supplemental material for Role of nitric oxide signaling in the antidepressant mechanism of action of ketamine: A randomized controlled trial
100. sj-docx-2-jop-10.1177_0269881120985147 – Supplemental material for Role of nitric oxide signaling in the antidepressant mechanism of action of ketamine: A randomized controlled trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.